Literature DB >> 8336148

Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons.

C Arias1, N Sharma, P Davies, B Shafit-Zagardo.   

Abstract

Microtubules and their associated proteins play a prominent role in many physiological and morphological aspects of brain function. Abnormal deposition of the microtubule-associated proteins (MAPs), MAP2 and tau, is a prominent aspect of Alzheimer's disease. MAP2 and tau are heat-stable phosphoproteins subject to high rates of phosphorylation/dephosphorylation. The phosphorylation state of these proteins modulates their affinity for tubulin and thereby affects the structure of the neuronal cytoskeleton. The dinoflagellate toxin okadaic acid is a potent and specific inhibitor of protein phosphatases 1 and 2A. In cultured rat cortical neurons and a human neuroblastoma cell line (MSN), okadaic acid induces increased phosphorylation of MAP2 and tau concomitant with early changes in the neuronal cytoskeleton and ultimately leads to cell death. These results suggest that the diminished rate of MAP2 and tau dephosphorylation affects the stability of the neuronal cytoskeleton. The effect of okadaic acid was not restricted to neurons. Astrocytes stained with antibodies to glial fibrillary acidic protein (GFAP) showed increased GFAP staining and changes in astrocyte morphology from a flat shape to a stellate appearance with long processes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8336148     DOI: 10.1111/j.1471-4159.1993.tb02172.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases.

Authors:  R Tapia; F Peña; C Arias
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

2.  Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner.

Authors:  Zhang Zhang; James W Simpkins
Journal:  Brain Res       Date:  2010-05-07       Impact factor: 3.252

3.  Human high intelligence is involved in spectral redshift of biophotonic activities in the brain.

Authors:  Zhuo Wang; Niting Wang; Zehua Li; Fangyan Xiao; Jiapei Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

4.  Mechanism of okadaic acid-induced neuronal death and the effect of estrogens.

Authors:  Kun Don Yi; Douglas F Covey; James W Simpkins
Journal:  J Neurochem       Date:  2008-11-28       Impact factor: 5.372

5.  A spatial gradient of tau protein phosphorylation in nascent axons.

Authors:  J W Mandell; G A Banker
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

Review 6.  Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease.

Authors:  Ana Gabriela Henriques; Joana Machado Oliveira; Liliana Patrícia Carvalho; Odete A B da Cruz E Silva
Journal:  Mol Neurobiol       Date:  2014-10-26       Impact factor: 5.590

Review 7.  The role of axonal cytoskeleton in diabetic neuropathy.

Authors:  W G McLean
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

8.  Epilepsy, neurodegeneration, and extracellular glutamate in the hippocampus of awake and anesthetized rats treated with okadaic acid.

Authors:  Nadia Ramírez-Munguía; Gabriela Vera; Ricardo Tapia
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

9.  Luteinizing hormone receptor activation in ovarian granulosa cells promotes protein kinase A-dependent dephosphorylation of microtubule-associated protein 2D.

Authors:  Maxfield P Flynn; Evelyn T Maizels; Amelia B Karlsson; Thomas McAvoy; Jung-Hyuck Ahn; Angus C Nairn; Mary Hunzicker-Dunn
Journal:  Mol Endocrinol       Date:  2008-05-08

10.  Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.

Authors:  Octavio Mercado-Gómez; Karla Hernández-Fonseca; Alexa Villavicencio-Queijeiro; Lourdes Massieu; Jesús Chimal-Monroy; Clorinda Arias
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.